Index
RUT
Market Cap
4.29B
Enterprise Value
5.62B
Income
103.70M
Sales
1.82B
Book/sh
50.78
Cash/sh
0.42
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
11000
IPO
Sep 29, 2000
P/E
42.28
Forward P/E
18.40
PEG
4.06
P/S
2.36
P/B
2.49
P/C
303.78
P/FCF
52.46
EV/EBITDA
18.51
EV/Sales
3.09
Quick Ratio
2.60
Current Ratio
3.98
Debt/Eq
0.78
LT Debt/Eq
0.77
Option/Short
Yes / Yes
EPS (ttm)
2.99
EPS next Y
6.86
EPS next Q
1.78
EPS this Y
-3.85%
EPS next Y
11.50%
EPS next 5Y
4.53%
EPS past 3/5Y
13.83% 4.37%
Sales past 3/5Y
10.24% 11.47%
EPS Y/Y TTM
53.15%
Sales Y/Y TTM
-0.33%
EPS Q/Q
-61.16%
Sales Q/Q
-3.63%
Insider Own
14.60%
Insider Trans
-0.82%
Inst Own
119.73%
Inst Trans
4.72%
ROA
3.05%
ROE
5.97%
ROIC
3.39%
Gross Margin
22.09%
Oper. Margin
9.03%
Profit Margin
5.69%
SMA20
-0.26%
SMA50
0.05%
SMA200
25.25%
Trades
Shs Outstand
34.00M
Shs Float
29.04M
52W High
126.83 -0.45%
52W Low
62.00 103.65%
Volatility
0.14% 0.12%
ATR (14)
0.23
RSI (14)
51.31
Beta
0.60
Rel Volume
0.00
Avg Volume
1.11M
Volume
11
Perf Week
-0.22%
Perf Month
-0.13%
Perf Quarter
1.45%
Perf Half Y
50.26%
Perf YTD
60.98%
Perf Year
99.40%
Perf 3Y
57.04%
Perf 5Y
40.26%
Perf 10Y
484.27%
Prev Close
126.52
Price
126.26
Change %
-0.21%
Analysts 11 incl. previous ratings
Rating Distribution 7 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside May 13, 2026 Upgrade O Oppenheimer
Perform → Outperform $115 -8.9% Feb 20, 2026 Upgrade T The Benchmark Company
Hold → Buy $95 -24.8% Oct 24, 2025 Downgrade W Wells Fargo
Overweight → Equal Weight $80 -36.6% Oct 24, 2025 Downgrade T The Benchmark Company
Buy → Hold Oct 24, 2025 Downgrade C Citigroup
Buy → Neutral $77 -39.0% Oct 24, 2025 Downgrade B BofA Securities
Buy → Neutral $87 -31.1% Oct 24, 2025 Downgrade A Argus
Buy → Hold May 22, 2025 Upgrade C Citigroup
Neutral → Buy $140 +10.9% Mar 28, 2025 Initiated R Raymond James
Outperform $145 +14.8% Feb 21, 2025 Downgrade O Oppenheimer
Outperform → Perform Dec 03, 2024 Resumed W Wells Fargo
Overweight $160 +26.7% Jul 16, 2024 Initiated O Oppenheimer
Outperform $135 +6.9% May 15, 2024 Initiated T Truist
Buy $137 +8.5% Apr 15, 2024 Upgrade B BofA Securities
Neutral → Buy $105 → $135 +6.9% Mar 14, 2024 Initiated C CL King
Buy $137 +8.5% Feb 06, 2024 Resumed K KeyBanc Capital Markets
Overweight $125 -1.0% May 26, 2023 Initiated W Wells Fargo
Equal Weight $87 -31.1% May 11, 2023 Initiated C Citigroup
Neutral $88 -30.3% Mar 30, 2023 Initiated B BofA Securities
Neutral $86 -31.9% Feb 24, 2023 Initiated P Piper Sandler
Overweight $85 -32.7%
Show Previous Ratings
Oct-29-26 08:21AM
08:00AM
Oct-21-26 04:43PM
Oct-02-26 04:05PM
Sep-30-26 08:00AM
01:53PM
Loading…
Sep-29-26 01:53PM
Sep-25-26 07:38AM
Sep-18-26 12:56PM
Sep-11-26 12:28PM
Sep-02-26 10:40AM
Aug-24-26 07:52AM
Aug-19-26 08:00AM
Aug-17-26 10:13PM
Aug-07-26 01:21PM
Aug-04-26 05:53AM
01:41PM
Loading…
Aug-03-26 01:41PM
08:25AM
07:15AM
07:03AM
(The Wall Street Journal)
06:37AM
06:31AM
06:30AM
Jul-31-26 03:51PM
03:11PM
(The Wall Street Journal)
Jul-02-26 08:00AM
Jun-03-26 08:00AM
May-15-26 06:26PM
Apr-30-26 08:13AM
(Associated Press)
+5.78%
08:00AM
08:00AM
08:00AM
Loading…
Apr-29-26 08:00AM
Apr-06-26 05:00PM
Apr-02-26 08:00AM
Mar-12-26 08:00AM
Mar-06-26 10:13AM
Feb-26-26 11:32PM
12:35AM
Feb-24-26 08:00AM
Feb-23-26 12:07PM
Feb-20-26 12:00PM
11:44AM
12:34AM
Feb-19-26 04:01PM
12:05PM
10:00AM
09:15AM
08:31AM
08:11AM
(Associated Press Finance)
08:00AM
Feb-17-26 10:04PM
Feb-12-26 05:30PM
Jan-28-26 09:00AM
08:00AM
Jan-23-26 07:29AM
Jan-22-26 11:08AM
08:00AM
Jan-18-26 11:07PM
Jan-16-26 02:52AM
Jan-14-26 08:00AM
02:43AM
Jan-13-26 09:06AM
Jan-09-26 09:00AM
Jan-06-26 09:00AM
Dec-29-25 01:34AM
Dec-28-25 11:34PM
Dec-22-25 07:00AM
Dec-19-25 09:00AM
Dec-17-25 05:00PM
(The Wall Street Journal)
+5.92%
Nov-18-25 08:00AM
Nov-10-25 04:27AM
Nov-04-25 08:00AM
Oct-30-25 01:36AM
Oct-27-25 09:45AM
Oct-25-25 08:30AM
Oct-24-25 01:53PM
09:56AM
09:34AM
09:18AM
09:00AM
08:00AM
Oct-23-25 03:50PM
03:08PM
11:29AM
09:30AM
09:20AM
09:15AM
08:34AM
08:17AM
(Associated Press Finance)
08:00AM
Oct-21-25 11:07PM
Oct-13-25 11:40AM
05:34AM
Oct-10-25 11:04AM
12:02AM
Oct-07-25 12:00PM
09:40AM
Oct-03-25 09:40AM
Sep-26-25 11:40AM
Sep-25-25 08:00AM
Sep-24-25 11:31PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Thor Kirk K Chief Human Resources Officer Sep 14 '26 Sale 126.25 19,773 2,496,430 18,920 Sep 16 08:33 PM Thor Kirk K Chief Human Resources Officer Sep 15 '26 Sale 126.23 11,767 1,485,295 7,153 Sep 16 08:33 PM Thor Kirk K Officer Sep 15 '26 Proposed Sale 126.30 4,700 593,610 Sep 15 04:44 PM Thor Kirk K Officer Sep 11 '26 Proposed Sale 126.20 31,540 3,980,348 Sep 11 04:26 PM Senn Andrew President, Growth & Innovation Sep 08 '26 Sale 126.30 9,408 1,188,230 5,405 Sep 10 04:32 PM Senn Andrew Officer Sep 08 '26 Proposed Sale 126.30 9,408 1,188,230 Sep 08 09:54 AM Stephens Jim President, CRM & Neuro May 15 '26 Option Exercise 0.00 1,963 0 6,331 May 19 04:28 PM Smith Diron EVP, Chief Financial Officer May 08 '26 Option Exercise 0.00 2,063 0 13,422 May 12 06:00 PM Thomas Tommy P VP, Corporate Controller Mar 13 '26 Sale 85.00 825 70,125 4,381 Mar 17 05:15 PM BAILEY PAMELA G Director Jan 02 '26 Option Exercise 48.43 2,883 139,624 56,052 Jan 05 07:29 PM MAXWELL MARTIN C Director Dec 12 '25 Option Exercise 48.43 2,883 139,624 25,053 Dec 16 07:20 PM Harris John A EVP, Global Ops and Manufactur Nov 12 '25 Buy 70.00 1,650 115,500 6,066 Nov 13 04:18 PM Thomas Tommy P VP, Corporate Controller Nov 11 '25 Sale 70.15 884 62,013 3,596 Nov 13 08:12 AM Smith Diron EVP, Chief Financial Officer Nov 07 '25 Buy 67.19 1,116 74,967 7,698 Nov 10 08:19 AM Capps Cheryl C Director Nov 06 '25 Buy 66.70 1,600 106,720 11,702 Nov 10 08:16 AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
CEO Mr. Payman Khales
Executive VP & CFO Mr. Diron Smith
Senior VP Ms. Lindsay Krause Blackwood J.D.
President of Growth & Innovation Mr. Andrew Senn
Executive Vice President of Special Projects Mr. Jim Stephens